Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04698629 · ClinicalTrials.gov registry record
Hepatitis C Pharmacy-based Strategy for Injectors
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 40
- Enrollment target
NCT04698629 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 40 participants.
The verdict
NCT04698629 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The aim of this study is evaluate the acceptability/usage of a newly implemented model of delivery of care, namely a community-pharmacy program, to provide access to medications to treat hepatitis C (HCV), and prevent overdose and HIV, for persons who inject drugs (PWID) with HCV who are in need of treatment. Adults will be enrolled who test positive for HCV at community sites and who agree to linkage to the community-pharmacy program through the use of patient navigators. The primary outcome of the study will be the measure of the number/% of participants who are successfully linked to the community-pharmacy program and assess HCV treatment initiation, completion, and cure. In addition, other outcomes including receipt of other medications (e.g. Naloxone, pre-exposure prophylaxis (PrEP), and medications for opioid use disorders), and self-reported substance use and HIV risk behaviors will also be measured.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-11-05 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04698629
The ClinicalTrials.gov registry entry for NCT04698629 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04698629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04698629 about?
NCT04698629 is a clinical study titled "Hepatitis C Pharmacy-based Strategy for Injectors". The aim of this study is evaluate the acceptability/usage of a newly implemented model of delivery of care, namely a community-pharmacy program, to provide access to medications to treat hepatitis C (HCV), and prevent overdose and HIV, for persons who inject drugs (PWID) with HCV who are in need of ...
What is the current status of trial NCT04698629?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2020-11-05. Estimated completion is 2023-06-30.
Who is sponsoring clinical trial NCT04698629?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.